Watson Nears €4.5 Billion Actavis Deal

Watson Pharmaceuticals is close to buying rival Actavis in a deal that values the Swiss-based company at about €4.5 billion, a person familiar with the matter said.

Topics:  watson pharmaceuticals   actavis   swiss-based   billion   deal   

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News